Cheng, Quan

Tissue macrophages: origin, heterogenity, biological functions, diseases and therapeutic targets

Guan, F., Wang, R., Yi, Z., Luo, P., Liu, W., Xie, Y., Liu, Z., Xia, Z., Zhang, H., & Cheng, Q. (2025) · Signal Transduction and Targeted Therapy

Immune cells in cancerPhagocytosis and Immune Regulation

Cited by 371

Psychiatric disorders associated with immune checkpoint inhibitors: a pharmacovigilance analysis of the FDA Adverse Event Reporting System (FAERS) database

Zhou, C., Peng, S., Lin, A., Jiang, A., Peng, Y., Gu, T., Liu, Z., Cheng, Q., Zhang, J., & Luo, P. (2023) · eClinicalMedicine

Cancer Immunotherapy and BiomarkersPharmacovigilance and Adverse Drug Reactions

Cited by 213

CAMOIP: a web server for comprehensive analysis on multi-omics of immunotherapy in pan-cancer

Lin, A., Qi, C., Wei, T., Li, M., Cheng, Q., Liu, Z., Luo, P., & Zhang, J. (2022) · Briefings in Bioinformatics

Cancer Immunotherapy and BiomarkersBioinformatics and Genomic Networks

Cited by 152

Gamma delta T-cell-based immune checkpoint therapy: attractive candidate for antitumor treatment

Gao, Z., Bai, Y., Lin, A., Jiang, A., Zhou, C., Cheng, Q., Liu, Z., Chen, X., Zhang, J., & Luo, P. (2023) · Molecular Cancer

Cancer Immunotherapy and BiomarkersT-cell and B-cell Immunology

Cited by 138

The role of DNA damage repair (DDR) system in response to immune checkpoint inhibitor (ICI) therapy

Shi, C., Qin, K., Lin, A., Jiang, A., Cheng, Q., Liu, Z., Zhang, J., & Luo, P. (2022) · Journal of Experimental & Clinical Cancer Research

Cancer Immunotherapy and BiomarkersDNA Repair Mechanisms

Cited by 85

The Basic Characteristics of the Pentraxin Family and Their Functions in Tumor Progression

Wang, Z., Wang, X., Zou, H., Dai, Z., Feng, S., Zhang, M., Xiao, G., Liu, Z., & Cheng, Q. (2020) · Frontiers in Immunology

Biomarkers in Disease MechanismsCytokine Signaling Pathways and Interactions

Cited by 73

HPVTIMER: A shiny web application for tumor immune estimation in human papillomavirus‐associated cancers

Liu, L., Xie, Y., Yang, H., Lin, A., Dong, M., Wang, H., Zhang, C., Liu, Z., Cheng, Q., Zhang, J., et al. (2023) · iMeta

Cancer Immunotherapy and BiomarkersCervical Cancer and HPV Research

Cited by 62

MHC-II Signature Correlates With Anti-Tumor Immunity and Predicts anti-PD-L1 Response of Bladder Cancer

Yi, R., Hong, S., Zhang, Y., Lin, A., Ying, H., Zou, W., Wang, Q., Wei, T., Cheng, Q., Zhu, W., et al. (2022) · Frontiers in Cell and Developmental Biology

Cancer Immunotherapy and BiomarkersBladder and Urothelial Cancer Treatments

Cited by 37